Efficacy of β-Lactam/β-Lactamase Inhibitor Combinations for the Treatment of Bloodstream Infection Due to Extended-Spectrum-β-Lactamase-Producing Enterobacteriaceae in Hematological Patients with Neutropenia

β-Lactam/β-lactamase inhibitors (BLBLIs) were compared to carbapenems in two cohorts of hematological neutropenic patients with extended-spectrum-β-lactamase (ESBL) bloodstream infection (BSI): the empirical therapy cohort (174 patients) and the definitive therapy cohort (251 patients). The 30-day c...

Cijeli opis

Spremljeno u:
Bibliografski detalji
Izdano u:Antimicrob Agents Chemother
Glavni autori: Gudiol, Carlota, Royo-Cebrecos, Cristina, Abdala, Edson, Akova, Murat, Álvarez, Rocío, Maestro-de la Calle, Guillermo, Cano, Angela, Cervera, Carlos, Clemente, Wanessa T., Martín-Dávila, Pilar, Freifeld, Alison, Gómez, Lucía, Gottlieb, Thomas, Gurguí, Mercè, Herrera, Fabián, Manzur, Adriana, Maschmeyer, Georg, Meije, Yolanda, Montejo, Miguel, Peghin, Maddalena, Rodríguez-Baño, Jesús, Ruiz-Camps, Isabel, Sukiennik, Teresa C., Tebe, Cristian, Carratalà, Jordi
Format: Artigo
Jezik:Inglês
Izdano: American Society for Microbiology 2017
Teme:
Clinical Therapeutics
Online pristup:https://ncbi.nlm.nih.gov/pmc/articles/PMC5527609/
https://ncbi.nlm.nih.gov/pubmed/28584145
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1128/AAC.00164-17
Oznake: Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!

Similar Items